220 related articles for article (PubMed ID: 31429685)
41. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X
Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
[TBL] [Abstract][Full Text] [Related]
42. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery.
Soler E; Parez N; Passet B; Dubuquoy C; Riffault S; Pillot M; Houdebine LM; Schwartz-Cornil I
Vaccine; 2007 Aug; 25(34):6373-80. PubMed ID: 17629366
[TBL] [Abstract][Full Text] [Related]
43. Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice.
Afchangi A; Jalilvand S; Arashkia A; Latifi T; Farahmand M; Abolghasem Shirazi MM; Mousavi Nasab SD; Marashi SM; Roohvand F; Shoja Z
Microb Pathog; 2022 Feb; 163():105405. PubMed ID: 35045328
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein.
Rota RP; Palacios CA; Temprana CF; Argüelles MH; Mandile MG; Mattion N; Laimbacher AS; Fraefel C; Castello AA; Glikmann G
J Virol Methods; 2018 Jun; 256():24-31. PubMed ID: 29496429
[TBL] [Abstract][Full Text] [Related]
45. [Optimization of the codon strengthened the human rotavirus VP6 antigen's serum immune responses and protective responses in mice model].
Wang M; Wu F; Song JD; Qu JG; Wang JW; Hong T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):22-4. PubMed ID: 22919745
[TBL] [Abstract][Full Text] [Related]
46. The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response.
Esquivel FR; Lopez S; Guitierrez-X L; Arias C
Arch Virol; 2000; 145(4):813-25. PubMed ID: 10893159
[TBL] [Abstract][Full Text] [Related]
47. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
[TBL] [Abstract][Full Text] [Related]
48. Induction of immune responses and partial protection in mice after skin immunization with rotavirus VP6 protein and the adjuvant LT(R192G).
Choi AH; Smiley K; Basu M
Vaccine; 2005 Mar; 23(17-18):2290-3. PubMed ID: 15755613
[TBL] [Abstract][Full Text] [Related]
49. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection.
Dong JL; Liang BG; Jin YS; Zhang WJ; Wang T
Virology; 2005 Sep; 339(2):153-63. PubMed ID: 15992851
[TBL] [Abstract][Full Text] [Related]
50. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
McNeal MM; Stone SC; Basu M; Clements JD; Choi AH; Ward RL
Viral Immunol; 2007 Dec; 20(4):571-84. PubMed ID: 18158731
[TBL] [Abstract][Full Text] [Related]
51. VP6: A candidate rotavirus vaccine.
Ward RL; McNeal MM
J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
[TBL] [Abstract][Full Text] [Related]
52. Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies.
Saldaña S; Esquivel Guadarrama F; Olivera Flores Tde J; Arias N; López S; Arias C; Ruiz-Medrano R; Mason H; Mor T; Richter L; Arntzen CJ; Gómez Lim MA
Viral Immunol; 2006; 19(1):42-53. PubMed ID: 16553549
[TBL] [Abstract][Full Text] [Related]
53. Intracellular neutralisation of rotavirus by VP6-specific IgG.
Caddy SL; Vaysburd M; Wing M; Foss S; Andersen JT; O'Connell K; Mayes K; Higginson K; Iturriza-Gómara M; Desselberger U; James LC
PLoS Pathog; 2020 Aug; 16(8):e1008732. PubMed ID: 32750093
[TBL] [Abstract][Full Text] [Related]
54. HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.
Laimbacher AS; Esteban LE; Castello AA; Abdusetir Cerfoglio JC; Argüelles MH; Glikmann G; D'Antuono A; Mattion N; Berois M; Arbiza J; Hilbe M; Schraner EM; Seyffert M; Dresch C; Epstein AL; Ackermann M; Fraefel C
Mol Ther; 2012 Sep; 20(9):1810-20. PubMed ID: 22713696
[TBL] [Abstract][Full Text] [Related]
55. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.
Schwartz-Cornil I; Benureau Y; Greenberg H; Hendrickson BA; Cohen J
J Virol; 2002 Aug; 76(16):8110-7. PubMed ID: 12134016
[TBL] [Abstract][Full Text] [Related]
56. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA.
Wu YZ; Li JT; Mou ZR; Fei L; Ni B; Geng M; Jia ZC; Zhou W; Zou LY; Tang Y
Virology; 2003 Sep; 313(2):337-42. PubMed ID: 12954202
[TBL] [Abstract][Full Text] [Related]
57. Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring.
Coste A; Cohen J; Reinhardt M; Kraehenbuhl JP; Sirard JC
Vaccine; 2001 Jul; 19(30):4167-74. PubMed ID: 11457542
[TBL] [Abstract][Full Text] [Related]
58. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response.
Choi NW; Estes MK; Langridge WH
J Biotechnol; 2006 Jan; 121(2):272-83. PubMed ID: 16181698
[TBL] [Abstract][Full Text] [Related]
59. Protective immunity induced by rotavirus DNA vaccines.
Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
[TBL] [Abstract][Full Text] [Related]
60. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.
McNeal MM; Basu M; Bean JA; Clements JD; Lycke NY; Ramne A; Löwenadler B; Choi AH; Ward RL
Vaccine; 2007 Aug; 25(33):6224-31. PubMed ID: 17629371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
